News

TD Cowen Maintains Hold Rating on Merck After Enflonsia Vaccine Update
Merck & Co., Inc. (NYSE:MRK) ranks among the best set-it-and-forget-it stocks to buy. On June 27, TD Cowen maintained its Hold rating and $100 price target on Merck & Co., Inc. (NYSE:MRK) after a vote ...
DPA International on MSN2d
German pharma giant Merck takes over US cancer specialist
German pharmaceutical giant Merck has completed a €3 billion ($3.5 billion) takeover of US biopharmaceutical company ...
Dividend Yield Theory Says Merck Is A Buy
Merck & Co., Inc.'s 4.09% dividend yield and robust pipeline signal strong growth potential. Click here to read an analysis ...
Contract Pharma3d
Merck KGaA, Darmstadt, Germany Acquires SpringWorks Therapeutics for $3.4M
Merck KGaA, Darmstadt, Germany has closed the acquisition of SpringWorks Therapeutics Inc. for an enterprise value of $3.4 billion.